Pearson
This article was originally published in The Tan Sheet
Executive Summary
Decision on antioxidant vitamins/cancer claim postponed until May 4, FDA says in letter to Emord & Associates. Agency, which had expected to issue oft-delayed determination by April 20, says its response will exceed 60 pages